Tomas Mariano Grippo

Tomas Mariano Grippo

Auto-generated profile, based on publicly available information

Tomas Mariano Grippo

Grippo Glaucoma and Cataract Center, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
FSF.G. Sanchez
F.G. Sanchez
FLF. Lerner
F. Lerner
JSJ. Sampaolesi
J. Sampaolesi
RNR. Noecker
R. Noecker
NBN. Becerra
N. Becerra
TGT.M. Grippo
T.M. Grippo

1 June 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
TGTomas M Grippo
Tomas M Grippo
RCRonald Mpc de Crom
Ronald Mpc de Crom
MGMichael Giovingo
Michael Giovingo
MTMarc Töteberg-Harms
Marc Töteberg-Harms
BFBrian A Francis
Brian A Francis
RNRobert Noecker
Robert Noecker
Purpose: To provide consensus-based current guidelines on optimal dosimetry and patient selection for MicroPulse Transscleral Laser Therapy (TLT) based on a review of the literature and a Delphi method. Methods: A comprehensive search of Pub Med led to the identification and analysis of 61 studies on MicroPulse TLT that contained information on laser settings and patient selection. To determine consensus in areas where there was not enough available literature, a three-round Delphi method was conducted. Results: The response rate was 90% in the first round, 90% in the second round, and 80% in the third round of the Delphi technique. Once all responses were aggregated, a live meeting was held with 80% attendance, and consensus was achieved on each of the findings detailed in this manuscript. Conclusion: Micropulse TLT is a useful addition to the glaucoma armamentarium. When used with proper surgical technique at energy settings within the boundaries described in this manuscript, MicroPulse TLT is a safe and effective treatment for many types and stages of glaucoma. Based on current knowledge and experience, the consensus recommendation of this expert panel is that the standard MicroPulse TLT settings using the revised MicroPulse P3 Probe should be 2500 mW, 31.3% duty cycle, and 4 sweeps at a sweep velocity of 20 seconds each per hemisphere. Both hemispheres avoiding the 3 and 9 clock hours should be treated. The panel also reached consensus on patient selection for MicroPulse TLT providing guidance for the use of the procedure.

1 June 2021 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
TGTomas M Grippo
Tomas M Grippo
FSFacundo G Sanchez
Facundo G Sanchez
JSJoan Stauffer
Joan Stauffer
GMGeorge Marcellino
George Marcellino
Since the first peer-reviewed publication on MicroPulse® Transscleral Laser Therapy (MP-TLT) in 2010, authors worldwide have used a wide range of treatment parameter combinations with varying clinical efficacy in terms of the magnitude of intraocular pressure reduction, success rate, durability, and safety profile. This has made it difficult to determine the proper parameters necessary to optimize efficacy and safety, and has made comparison of results from one investigation to another difficult. The first goal of this paper is to explain and highlight the impact of the choices of exposure time and the number of sweeps per hemisphere in terms of “sweep velocity” on energy delivery to the eye. These treatment parameters are underreported in the literature. The second goal is to introduce fluence as a “dose” metric, that combines all the treatment parameters and constants into a single number. Fluence may be a better light-dose metric and a more reliable indicator of clinical outcomes compared to total energy.

1 January 2023 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
TGTomas M Grippo
Tomas M Grippo
MTMarc Töteberg-Harms
Marc Töteberg-Harms
MGMichael Giovingo
Michael Giovingo
BFBrian A Francis
Brian A Francis
RCRonald Rmpc de Crom
Ronald Rmpc de Crom
RNRobert Noecker
Robert Noecker
Purpose: To provide expert consensus and evidence-based current guidelines on treatment technique, postoperative care, expected outcomes and retreatment for MicroPulse Transscleral Laser Treatment (TLT). Methods: A comprehensive search of PubMed led to the identification and analysis of 61 studies on MicroPulse TLT. To provide guidance in areas where there was not enough available literature, a three-round Delphi method was conducted involving 10 international experts in MicroPulse TLT. Results: The response rate was 70% in the first round, 70% in the second round, and 80% in the third round of the Delphi method. Once all responses were aggregated, a live meeting was held with 90% attendance, and consensus was achieved on each of the findings detailed in this manuscript. Conclusion: Used within appropriate treatment parameters, with proper technique and patient selection, MicroPulse TLT is a safe and effective treatment for many types and severities of glaucoma. MicroPulse TLT represents a useful addition to the glaucoma armamentarium.

1 September 2009 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
TGTomas M. Grippo
Tomas M. Grippo
IEIsaac Ezon
Isaac Ezon
FKFabio N. Kanadani
Fabio N. Kanadani
BWBoonchai Wangsupadilok
Boonchai Wangsupadilok
CTCelso Tello
Celso Tello
DHDonald C. Hood
Donald C. Hood
Purpose. To determine the effect of optic disc drusen on the latency of the pattern-reversal checkerboard visual evoked potentials (VEPs) and multifocal (mf)VEPs and to better understand the pathophysiology of the condition. methods. Eighteen eyes with optic disc drusen (10 patients) and 38 control eyes (19 subjects) underwent VEP, mfVEP, and visual field testing. Only one eye of each individual, the one with the more affected visual field, was used in the analyses. The VEPs were recorded with a 15′ and 60′ reversing checkerboard pattern, and the mfVEPs were elicited by a 60-sector dartboard display. results. Unlike the VEP results, the mfVEP revealed a significant increase in the average monocular latency of the optic disc drusen group compared with that of the control group. The average mfVEP relative latency for the optic disc drusen group (4.1 ms) was greater than that (0.8 ms) in the control group. For monocular and interocular analyses, the average percentage of points delayed in the drusen group was significantly greater than that in the control group. conclusions. Optic disc drusen produced significant latency delays on the mfVEP test but not on the VEP test, presumably due to the mfVEP’s ability to detect the effects of local changes. The results are consistent with the hypothesis that local mechanical compression by optic disc drusen leads to abnormal retinal ganglion cell activity.

1 September 2020 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
NBNatalie Brossard Barbosa
Natalie Brossard Barbosa
TGTomas M. Grippo
Tomas M. Grippo
To report for the first time the successful use of the Kahook Dual Blade excisional goniotomy technique in a patient with Transthyretin Amyloidosis. The Kahook Dual Blade is a single use ab interno trabeculectomy device that removes the trabecular meshwork reducing aqueous humor outflow resistance. A patient with Transthyretin Amyloidosis underwent this procedure. Ab interno goniotomy with Kahook Dual Blade was a successful surgical solution to reduce intraocular pressure in a patient with Transthyretin Amyloidosis secondary glaucoma controlling IOP in association with topical hypotensors for at least 6 months. Ab interno goniotomy with Kahook Dual Blade is a surgical option for this type of glaucoma, that treats the main site of aqueous outflow resistance in this pathology with the advantage of being minimally invasive.